The way we detect cancer is changing. Instead of relying solely on invasive tissue biopsies, the industry is shifting toward blood tests, advanced imaging, and liquid biopsy — methods that are faster, safer, and easier on patients. This shift is fueling rapid expansion of the non-invasive cancer diagnostics market, which is set to nearly double over the next decade as rising cancer...